Poster Abstract Session:
151. Viruses and Bacteria in Immunocompromised Patients
Friday, October 5, 2018: 12:30 PM-1:45 PM
Room: S Poster Hall

Tracks: Adult ID, Epidemiology and Infection Control, Investigative ID, Pediatric ID


Presentations:
Increased risk of bacterial, fungal and other viral infections during CMV infection: decreased cytokine production in response to Toll-like receptor ligands.
Arnaud G L'Huillier, MD; Deepali Kumar, MD Msc; Ilona Bahinskaya, CRC; Victor H. Ferreira, PhD; Atul Humar, MD
Posters
  • IDweek2018-dk.pdf (236.5 kB)
  • Posters
  • ID WEEK - Colistin.jpg (6.4 MB)
  • Utility of CT Abdomen in Evaluation of Neutropenic Fever in Patients with Hematological Malignancies
    Ruaa Al-Ward, M.B., CH.B.; Syed Ahsan Rizvi, M.D; Ahmed Hamdi, MD; Saira Farid, MD; M. Rizwan Sohail, MD
    Reactivation of latent cytomegalovirus infection in patients with rheumatologic disease: a case-control study
    Bradley Gardiner, MBBS, FRACP, MS; Erica Haas, BS; Rosemary Bailey, BS; Jennifer Chow, MD, MS; David Snydman, MD, FIDSA
    High Mortality of Cytomegalovirus (CMV) Pneumonia in Hematopietic Cell Transplant Recipients
    Marjorie Batista, MD, PhD; Fareed Khawaja, MD; Annette Artau, MD; Samuel L. Aitken, PharmD; Lynn El Haddad, PhD; Shashank S. Ghantoji, MD, PhD, MPH; Roy F. Chemaly, MD, MPH, FIDSA, FACP
    Left Ventricular Assist Device Driveline Infections: Relapsed Infections and Minimum Inhibitory Concentration Changes
    Tara Lines, PharmD; Leah Sabato, PharmD, BCPS; Whitney Nesbitt, PharmD, BCPS; Jeremy Moretz, PharmD, BCPS; Marshall Brinkley, MD; Gowri Satyanarayana, MD
    Posters
  • ID Week poster FINAL PDF.pdf (795.7 kB)
  • Infectious complications in patients (pt) following umbilical cord blood transplant (UCBT) for hematologic malignancy
    Kathleen A. Linder, MD; Philip McDonald, MD; Carol A. Kauffman, MD; Sanjay G. Revankar, MD; Pranatharthi H. Chandrasekar, MD; Marisa H. Miceli, MD
    Posters
  • UCBT ID week poster FINAL.pdf (352.2 kB)
  • The More Resistant, the More Fatal: Results of 414 Bacteremia Episodes in Febril Neutropenic Patients
    Serkan Surme, MD; Yusuf E. Ozdemir, MD; Meryem Sahin, MD; Ilker I. Balkan, Assoc Prof; Bilgul Mete, MD; Gunay Can, Prof; Fehmi Tabak, Prof; Nese Saltoglu, Prof Dr, MD
    Posters
  • IDWEEK 2018 POSTER 12.09.18.pdf (625.9 kB)
  • Kinetics of BK virus in urine associated with BKV DNAemia and BKVAN in pediatric kidney transplantation
    Masaki Yamada, MD; Lorne Walker, MD, PhD; Christina Nguyen, MD; Marian Michaels, MD, MPH; Micahel Green, MD, MPH
    Posters
  • 2018-10-05 1544 MYAMADA.pdf (1.2 MB)
  • Gram-negative Bacteremia in Neutropenic Patients: Risk Factors for Mortality in the Era of Multiresistance
    Fabián Herrera, MD; Ana Laborde, MD; Rosana Jordán, MD; Inés Roccia Rossi, MD; Graciela Guerrini, MD; Alejandra Valledor, Infectious Diseases Specialist; Patricia Costantini, MD; Miguel Dictar, MD; Andrea Nenna, MD; Juan Pablo Caeiro, MD; Diego Torres, MD; María Luz Gonzalez Ibañez, MD; Victoria Pinoni, MD; Facundo Argüello, MD; Martín Luck, MD; Agustina Racioppi, MD; Fernando Poletta, PhD; Alberto Carena, MD
    Posters
  • IDWeek. Poster 1545.pdf (1.7 MB)
  • BK Virus Reactivation in Solitary Heart Transplant Recipients: Prevalence and Relationship to Kidney Dysfunction
    Whitney Perry, MD; Lesley Inker, MD, MS; David DeNofrio, MD; Natalie Nierenberg, MD, MPH
    Risk of Severe Herpes Zoster (HZ) in Allogeneic Hematopoietic-cell Transplantation (HCT) Recipients
    Emily Baumrin, MD; Matthew P. Cheng, MD; Sanjat Kanjilal, MD, MPH; Nicolas Issa, MD; Lindsey Baden, MD
    Development and Validation of a Cycle-Specific Risk Score for Febrile Neutropenia after Chemotherapy in Patients with Cancer: The CSRFENCE Score
    Theis Aagaard, MD; Joanne Reekie, MPhil, PhD; Ashley Roen, MA; Gedske Daugaard, MD, DMSc, Professor; Henrik Sengeløv, MD; Lena Specht, MD, DMSc; Amanda Mocroft, MSc, Professor; Jens Lundgren, MD, DMSc, Professor; Marie Helleberg, MD, PhD, DMSc
    Posters
  • IDweek2018_TAA_final_v2.pdf (421.2 kB)
  • The impact of recurrent CMV disease on long-term survival in solid organ transplant recipients
    Bradley Gardiner, MBBS, FRACP, MS; Jennifer Chow, MD, MS; Sam Brilleman, BSc, MSc Med Stat; Anton Peleg, MBBS PhD MPH; David Snydman, MD, FIDSA
    Infectious complications following hematopoietic cell transplantation in patients with primary immunodeficiency diseases
    Surabhi Vora, MD, MPH; Janet Englund, MD, FIDSA; Aleksandra Petrovic, MD; Anne Woolfrey, MD; Kanwaldeep Mallhi, MD; Lauri Burroughs, MD
    Reactivation of Varicella Zoster Virus in Solid Organ Transplant Recipients: Identification of Risk Factors Using Data Mining Tools
    Ashley Wallace, BS; Nicolas Barros, MD; Donglu Xie, MS; Christina Yek, MD; Terrence Liu, BS; Xilong Li, PhD; Beverley Adams-Huet, MS; Robert W. Haley, MD, FSHEA; David Greenberg, MD; Ricardo La Hoz, MD, FACP, FAST
    Posters
  • AW Poster 6.pdf (437.3 kB)
  • A New Perspective About Disseminated Adenovirus Infection and Its Outcomes in Pediatric Solid Organ Transplantation
    Coralee Del Valle Mojica, MD MPH; Sharon F. Chen, MD, MS; Hayley A. Gans, MD, FPIDS
    Infectious Disease Complications with Use of Checkpoint Inhibitors in Solid Organ Malignancies
    Kellie Komoda, PharmD; Justine Abella Ross, PharmD; Kim Margolin, MD; Sumanta Pal, MD; Jana Dickter, MD; James Ito, MD; Ravi Salgia, MD; Sanjeet Dadwal, MD
    Acyclovir-resistant (ACV-R) herpes simplex virus (HSV) disease in patients with hematologic malignancies (HM) and hematopoietic-cell transplant (HCT) recipients
    Alisha Pandit, BA; Matthew P. Cheng, MD; Alexis Liakos, PA-C; Nathaniel Treister, DMD; DMSc; Lindsey R. Baden, MD; Nicolas C. Issa, MD; Francisco M Marty, MD; Sarah P. Hammond, MD
    Posters
  • R-HSV poster 01Oct18 FINAL.pdf (962.6 kB)
  • Commensal Neisseria Species as a Cause of Disease in Patients Taking Eculizumab
    Page Crew, PharmD, MPH; Lucy McNamara, PhD, MS; Peter Waldron, MD; Lynda McCulley, PharmD; S. Christopher Jones, PharmD, MS, MPH; Susan Bersoff-Matcha, MD
    Hematopoietic Cell Transplantation with Post-transplant Cyclophosphamide: Impact of Donor Type on Pre-engraftment Blood-stream Infections
    Chiara Oltolini, MD; Raffaella Greco, MD; Laura Galli, MD; Francesca Lorentino, MD; Elisabetta Xue, MD; Maria Teresa Lupo Stanghellini, MD; Daniela Clerici, MD; Fabio Giglio, MD; Jacopo Peccatori, MD; Massimo Bernardi, MD; Consuelo Corti, MD; Paolo Scarpellini, MD; Antonella Castagna, Prof; Fabio Ciceri, Prof
    Posters
  • IDWeek2018_1559.pdf (300.1 kB)
  • Clinical Presentation of BK virus-associated hemorrhagic cystitis (HC) after hematopoietic cell transplantation (HCT)
    Hannah Imlay, MD; Hu Xie, MSc; Wendy Leisenring, ScD; Louise Kimball, PhD; Steven Pergam, MD, MPH, FIDSA; Ajit Limaye, MD, FIDSA; Michael Boeckh, MD, PhD, FIDSA
    Posters
  • BK_poster2.pdf (656.0 kB)
  • Outcomes of Resistant or Refractory CMV Infection in Recipients of Allogeneic Hematopoietic Cell Transplant
    Annette Artau, MD; Samuel L. Aitken, PharmD; Marjorie Batista, MD, PhD; Firas El Chaer, MD; Amrita Prayag, MD; Lynn El Haddad, PhD; Victor Mulanovich, MD; Ella Ariza-Heredia, MD; Roy Chemaly, MD, MPH
    Impact of Skin Biopsy on Diagnosing Infections and Changing Treatment in Cancer Patients with New Skin Rash
    Niyati Jakharia, MD; Kristen Stafford, PhD, MPH; David J. Riedel, M.D., M.P.H.
    Posters
  • IDWeekposterfinal5.pdf (425.6 kB)
  • Relationship of cumulative viral burden of adenovirus with mortality in allogeneic hematopoietic cell transplant recipients with early adenovirus viremia
    Yeon Joo Lee, MD, MPH; Zinxuan Chen, BA; Miguel-Angel Perales, MD; Susan Prockop, MD; Genovefa Papanicolaou, MD
    Lower Rates of Epstein-Barr Virus (EBV) Viremia in Pediatric Solid Organ Transplant (SOT) Recipients Who Received Valganciclovir Prophylaxis
    Elizabeth A Moulton, MD, PhD; Manjiree Karandikar, MD, MBS; Sheila Bond, MD; Sandra Burchett, MD, MS; Tanvi Sharma, MD, MPH; Francisco M Marty, MD
    Is primary CMV infection post-transplant influenced by circadian rhythms?
    Hannah Rafferty, BA (Hons), BMBCh; Jerry Tam, MB BChir PhD; Colette Smith, PhD; Matthew Reeves, PhD; Jane McKeating, PhD; Dinesh Sharma, MBBS, MS, FRCSEd, FRCS (GENSURG); David Whitmore, PhD; Paul Griffiths, MD, DSc
    Posters
  • idweek poster 3-converted.pdf (228.7 kB)
  • Predicting mortality among immunocompromised patients who present with infection
    Oryan Henig, MD; Krishna Rao, MD, MS; Owen Albin, MD; Rosemary Putler, MS; Daniel Kaul, MD; Keith S. Kaye, MD
    Implementation of a Standard Diet Regimen for Neutropenic High Risk Cancer Patients: Effects on Incidence of Infections, Foodborne Diseases, and Outcome
    Carolin Jakob, M. Sc.; Annika Y. Löhnert, MD; Melanie Stecher, MSc. Public Health; Andreas Engert, Prof. Dr. med.; Meike Freund, MD; Axel Hamprecht, MD; Nathalie Jazmati, MD; Hilmar Wisplinghoff, MD; Michael Hallek, Prof. Dr. med.; Oliver A. Cornely, MD; Janne Vehreschild, Prof. Dr. med.
    Incidence, Risk Factors, and Impact of Antiviral Prophylaxis Duration on Cytomegalovirus [CMV] Disease in High-Risk Donor Seropositive/Recipient Seronegative [D+R-] Orthotopic Heart Transplant Recipients [OHTR]
    Allison Dumitriu Carcoana, B.A. candidate; Hannah Imlay, MD; Cynthia Fisher, MD, MPH; Beatrice Wong, PharmD; Robert Rakita, MD; Ajit Limaye, MD, FIDSA
    Posters
  • CMV ID Week Poster 09.26.18.pdf (457.7 kB)
  • Cost-effectiveness analysis of duration of valganciclovir prophylaxis among CMV serology mismatched (donor+/recipient-) lung transplant recipients
    Heather Tomko, MA; Cornelius J. Clancy, M.D.; Cynthia Bryce, PhD; Mark Roberts, MD; Kenneth Smith, MD; M. Hong Nguyen, MD
    Conjugate Pneumococcal Vaccination Reduces Invasive Pneumococcal Disease Post Haemotopoietic Stem Cell Transplant
    Matthew B Roberts, MBBS, MPH&TM; Devendra K Hiwase, MBBS, MD, PhD, FRACP, FRCPA; Narin Bak, MBBS, FRACP, MPH
    Discrepancies Between Premortem and Postmortem Diagnoses of Infectious Diseases Found on Autopsy in Hematopoietic Cell Transplantation Recipients at a High-volume Academic Transplant Center
    Ashrit Multani, MD; Libby Allard, MD; Tamna Wangjam, MD; R. Alejandro Sica, MD; David J. Epstein, MD; Andrew Rezvani, MD; Dora Ho, MD, PhD
    Cancer Chemotherapy May Induce Acquisition of Antibiotic Resistance Genes in Antibiotic- Naïve Cancer Patients
    Senu Apewokin, MD; Heidi M Andersen, MD, MS; Stephen Medlin, DO; Tesfaye Mersha, PhD; Alison Weiss, PhD; David Haslam, MD; Stella M. Davies, MBBS
    Clinical Validation of a Novel ELISpot-based in vitro Diagnostic Assay to Monitor CMV-specific Cell-mediated Immunity in SOT and HSCT Immunocompromised Patients
    Bernhard Banas, MD; Dominik Steubl, MD; Lutz Renders, MD; Dominik Chittka, MD; Miriam Banas, MD; Thomas Wekerle, MD; Martina Koch, MD; Oliver Witzke, MD; Monika Lindemann, MD; Anja Muehlfeld, MD; Claudia Sommerer, MD; Antja Habicht, MD; Christian Hugo, MD; Thomas Huenig, MD; Stephan Mielke, MD; Martin Schreder, MD; Eva Wagner, MD; Daniel Teschner, MD; Stefan Klein, MD; Daniela Heidenreich, MD; Sebastian Kreil, MD; Kerstin Schaefer-Eckart, MD; Johannes Gaertner, MD; Mareike Verbeek, MD; Sandra Grass, MD; Christine Wolschke, MD; Dietlinde Janson, MD; Guido Kobbe, MD; Mustafa Kondakci, MD; Markus Ditschkowski, MD; Tanja Gromke, MD; Inken Hilgendorf, MD; Marie Von Lilienfeld-Toal, MD; Traudel Schmidt, PhD; Anne Rascle, PhD; Sascha Barabas, PhD; Ludwig Deml, PhD; Ralf Wagner, PhD; Bernhard Kraemer, MD; Bernd Krueger, MD; Daniel Wolff, MD
    Risk of Clinical Tuberculosis (TB) among Patients with Latent TB Infection (LTBI) who Undergo Allogeneic Hematopoietic-Cell Transplantation (HCT).
    Amanda E. Kusztos, BS; Matthew P. Cheng, MD; Tyler D. Bold, MD, PhD; Vincent T. Ho, MD; Brett E. Glotzbecker, MD; Candace Hsieh, RN, CIC; Meghan A. Baker, MD; Sarah P. Hammond, MD; Lindsey R. Baden, MD; Francisco M. Marty, MD
    Back to Bactrim – Utilizing preferred prophylaxis strategies in immunocompromised hosts via a trimethoprim-sulfamethoxazole rechallenge program
    Olivia Smibert, Bachelor of Medicine, Bachelor of Surgery; Karen Urbancic, BPharm; Abby Douglas, MBBS; Misha Devchand, BPharm; Monica Slavin, MBBS FRACP MD; Jason Trubiano, MBBS/BBioMed Sci FRACP
    Evaluation of MATCH: an Electronic Individual Patient-Focused Management System Aimed at Preventing Cytomegalovirus Disease Following Solid Organ Transplantation
    Christina Ekenberg, MD; Caspar Da Cunha-Bang, MD; Isabelle Paula Lodding, MD; Søren Schwartz Sørensen, MD; Henrik Sengeløv, MD; Michael Perch, MD; Allan Rasmussen, MD; Finn Gustafsson, MD; Neval Ete Wareham, MD; Nikolai Kirkby, MSc; Jesper Kjær, MSc; Marie Helleberg, MD; Jens D Lundgren, MD
    Impact of Colonization with Fluoroquinolone-Resistant Enterobacteriaceae on the Risk of Gram-Negative Bacteremia in Hematopoietic Stem Cell Transplant Recipients Who Receive Prophylactic Levofloxacin
    Michael J. Satlin, MD, MS; Claire Douglass, BS; Michael Hovan, BS; Rosemary Soave, MD, FIDSA; Anna Chan, MLS; Tsiporah B. Shore, MD; Koen Van Besien, MD, PhD; Sebastian Mayer, MD; Adrienne A. Phillips, MD, MPH; Jing-Mei Hsu, MD, PhD; Rianna Malherbe, BS; Stephen G. Jenkins, PhD; Barry N. Kreiswirth, PhD; Lars F. Westblade, PhD; Thomas J. Walsh, MD, PhD
    Is Antibiotic Prophylaxis Needed for All Acute Variceal Bleeds in Decompensated Cirrhosis? A Retrospective Pilot Study.
    Emil Thyssen, BS; Drew Hensel, BS; Nathanial Nolan, MD; Stevan Whitt, MD; Hariharan Regunath, MD
    The Utility of the Immunodeficiency Scoring Index (ISI) to Predict Outcomes of Coronavirus (HCoV) Infections in Hematopietic Cell Transplant (HCT) Recipients
    Fareed Khawaja, MD; Terri Lynn Shigle, PharmD, BCPS, BCOP; Shashank S. Ghantoji, MD, PhD, MPH; Marjorie Batista, MD, PhD; Ella Ariza-Heredia, MD; Roy F. Chemaly, MD, MPH, FIDSA, FACP
    Development and Dynamics of Cytomegalovirus UL97 Ganciclovir Resistance Mutations in Transplant Recipients Detected by Next Generation Sequencing
    Isabelle Paula Lodding, MD; Mette Jørgensen, PhD; Marc Bennedbæk, MSc. Engineering; Nikolai Kirkby, MSc; Klaudia Naegele, MSc.; Finn Gustafsson, MD; Michael Perch, MD; Allan Rasmussen, MD; Henrik Sengeløv, MD; Søren Schwartz Sørensen, MD; Hans Hirsch, MD; Jens D Lundgren, MD
    BLOODSTREAM INFECTION SURVEY in HIGH-RISK ONCOLOGY PATIENTS (BISHOP) with FEVER AND NEUTROPENIA (FN): Correlation between Initial Empiric Antibiotic Regimen Correlation and Susceptibility Patterns
    Andrea Zimmer, MD; Alison G. Freifeld, MD; Christopher Arnold, MD; John W. Baddley, MD; Pranatharthi Chandrasekar, MD; Zeinab El Boghdadly, MBBCh; Carlos Gomez, MD; Eileen K. Maziarz, MD; Steven Pergam, MD, MPH, FIDSA; Kenneth V. Rolston, MD; Gowri Satyanarayana, MD; Shmuel Shoham, MD; Lynne Strasfeld, MD; Randy Taplitz, MD; Thomas J. Walsh, MD, PhD; Jo-Anne Young, MD; Jane Meza, PhD; Yuning Zhang, Ph.D
    Prevalence and Significance of Pre-Transplant BK Viremia and Viruria in Deceased and Living Kidney Donors and Kidney Transplant Recipients
    Susanna K. Tan, MD; Malaya K. Sahoo, PhD; ChunHong Huang, PhD; Jenna Weber, BS; Jason Kurzer, MD, PhD; Waldo Concepcion, MD; Peter Chin-Hong, MD; Aruna Subramanian, MD, FIDSA; Jane Tan, MD; Benjamin Pinksy, MD, PhD
    Analysis of Breakthrough Blood Stream Infections in Left Ventricular Assist Device Recipients Managed with Chronic Antimicrobial Suppressive Therapy
    Deeksha Jandhyala, M.D.; John C O'horo, MD; Alan J. Wright, MD, FIDSA, FSHEA; Randall C. Walker, MD; John Stulak, MD; Andres Bran, MD; Larry M Baddour, MD; Saira Farid, MD; M Rizwan Sohail, MD
    Clinical Prediction Tool for Extended-Spectrum Beta Lactamase-Producing Enterobacteriaceae as the Etiology of Bacteremia in Solid Organ Transplant Recipients
    Rebecca Wang, MD; Ebbing Lautenbach, MD, MPH, MSCE, FIDSA, FSHEA; Jennifer Han, MD, MSCE; Emily Blumberg, MD, FIDSA; Pranita Tamma, MD, MHS; Kerri Thom, MD; Kevin Alby, PhD; Warren Bilker, PhD; Jacqueline Omorogbe, BS; Pam Tolomeo, MPH; Judith Anesi, MD
    Posters
  • ESBL Transplant Poster.pdf (3.0 MB)
  • Increased Detection of Diarrheal Pathogens in Hematopoietic Stem Cell Transplant Recipients using a Multiplexed PCR Panel
    Wesley Rogers, BA; Lars Westblade, PhD; Stephen G Jenkins, PhD; Koen Van Besien, MD, PhD; Harjot Singh, MD, ScM; Rosemary Soave, MD, FIDSA; Carl Crawford, MD; Michael Satlin, MD, MS
    Posters
  • ID week poster Rogers 2018.pdf (315.8 kB)
  • A Hybrid CMV Prevention Strategy is Effective in Preventing CMV Disease Outcomes in Pediatric Solid Organ Transplant Patients
    Lucia Dalle Ore, BS; Derek Boothroyd, PhD; Hayley A. Gans, MD, FPIDS; Sharon F. Chen, MD, MS
    Infectious outcomes of levofloxacin prophylaxis in obese versus non-obese patients with hematologic malignancies
    Amanda Kurtti, Pharm.D.; Kelly Fritz, Pharm.D., BCOP; Kathryn Elofson, Pharm.D.; Russell Benefield, Pharm.D., BCPS (AQ-ID)
    Safety of Oral Trimethoprim/Sulfamethoxazole Prophylaxis in Renal Transplant Recipients
    Courtney Horvat, PharmD; Thomas J. Dilworth, PharmD; Iram Nadeem, MD
    Posters
  • IDWeek Poster TMP-SMX FINAL.pdf (278.7 kB)
  • Recurrence of Clostridium difficile Infection in Multiple Myeloma patients Receiving Prophylactic Oral Vancomycin or Oral Metronidazole versus No Prophylaxis
    Gisele Moran, MPH; Naveen Yarlagadda, MD; Sandra Susanibar, MD; Atul Kothari, MD; Juan Carlos Rico, MD; Mary J Burgess, MD
    Posters
  • IDSA 2018 Poster Final.pdf (434.0 kB)
  • Evaluating Clinical Outcomes of an Alternative Cefepime Dosing Regimen as Empiric Antibiotic Therapy in Hospitalized Adults with Febrile Neutropenia
    Manuela Haiduc, PharmD; Derek Bremmer, PharmD, BCPS; Monank Patel, PharmD, BCPS, BCOP; Thomas Walsh, MD; Matthew Moffa, DO
    Posters
  • 1594_IDWPOSTER.pdf (228.7 kB)
  • Impact of levofloxacin for the prophylaxis of bloodstream infection on the gut microbiome in patients with hematologic malignancy
    Matthew Ziegler, MD; Jennifer H. Han, MD, MSCE; Daniel Landsburg, MD; David Pegues, MD, FIDSA, FSHEA; Emily Reesey, MS; Cheryl Gilmar, MS, MT, CIC; Theresa Gorman, MSN, RN, AOCNS; Kristen Bink, MSN, RN, AGCNS-BC; Amy Moore, MSN, RN, ACNS-BC; Brendan J. Kelly, MD, MS
    Thinking Locally: Can Unit-Specific Methicillin-Resistant Staphylococcus aureus Screening Augment Stewardship Interventions for Febrile Neutropenia?
    Rachel Bartash, MD; Belinda Ostrowsky, MD, MPH, FIDSA, FSHEA; Adam Binder, MD; Kelsie Cowman, MPH; Carol Sheridan, RN MSN OCN BMTCN; Yi Guo, PharmD; Michael Levi, ScD, (D) ABMM; Wendy Szymczak, PhD; Philip Gialanella, MS; Priya Nori, MD
    Risk Factors for Failure of Primary (Val)ganciclovir Prophylaxis Against Cytomegalovirus (CMV) Infection and Disease in Solid Organ Transplant (SOT) Recipients
    Mark Poulsen Khurana, Medical Student; Isabelle Paula Lodding, MD; Amanda Mocroft, MSc, Professor; Søren Schwartz Sørensen, MD; Michael Perch, MD; Allan Rasmussen, MD; Finn Gustafsson, MD; Jens Lundgren, MD, DMSc, Professor
    Posters
  • Poster_1597_KSH.pdf (566.9 kB)
  • Oral step down therapy with levofloxacin for low risk febrile neutropenia in children
    Sonia Mehra, MD; Jared A Olson, PharmD; Adam L. Hersh, MD, PhD; Emily Thorell, MD, MSCI; Richard Lemons, MD; Andrew Pavia, MD, FIDSA, FSHEA, FPIDS; Elizabeth Knackstedt, MD
    Rejection Outcomes in Lung Transplant Recipients Post Respiratory Syncytial Virus Infections
    Nitipong Permpalung, MD, MPH; Tany Thaniyavarn, MD; Jennifer Saullo, MD, PharmD; Sana Arif, MBBS; Rachel Miller, MD; John Reynolds, MD; Barbara D. Alexander, MD, MHS
    An Optimal Respiratory Syncytial Virus (RSV) Treatment in Lung Transplant Recipients: Oral Ribavirin, Inhaled Ribavirin, or Conservative Approach
    Nitipong Permpalung, MD, MPH; Tany Thaniyavarn, MD; Jennifer Saullo, MD, PharmD; Sana Arif, MBBS; Rachel Miller, MD; John Reynolds, MD; Barbara D. Alexander, MD, MHS, FIDSA
    Effect of Preemptive Rituximab Therapy on Epstein-Barr reactivation in Allogenic Hematopoietic Stem Cell Pediatric Transplants
    Gaud Catho, MD; Daniel Scheel, MSc; Pierre Teira, MD, MSc; Christian Renaud, MD, MSc, FRCPC; Lisa Kakinami, PhD; Philippe Ovetchkine, MD, MSc; Julie Autmizguine, MD, MSc, FRCPC
    Posters
  • POSTerGaudCATHO.pdf (1.2 MB)
  • Clostridium difficile Infection as a Predictor of Acute Graft versus Host Disease among Allogenic Stem Cell Transplant Recipients
    Ra'Ed Jabr, MBBchB; Leyla Shune, MD; Wissam El Atrouni, MD, MSc; Mohammad Telfah, MD; Guangyi Gao, Ms; Jianghua He, PhD; Lisa Clough, MD

    CME Credits: Maximum of 0.00 hours of AMA PRA Category 1 Credit™


    Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 3rd with the exception of research findings presented at the IDWeek press conferences.